Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis

European Journal of Dermatology

Volumn 23, Issue 2, 2013, Pages 273-274

  Chimenti, Maria Sole ^a   Teoli, Miriam ^a   Di Stefani, Alessandro ^b   Giunta, Alessandro ^a   Esposito, Maria ^a   Perricone, Roberto ^a  

^a Department of Rheumatology ^*  (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; C REACTIVE PROTEIN; CLOBETASOL PROPIONATE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ETANERCEPT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; RHEUMATOID FACTOR; RITUXIMAB; SALAZOSULFAPYRIDINE;

ABNORMAL LABORATORY RESULT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; ERYTHEMA; HISTOLOGY; HUMAN; LABORATORY TEST; MALE; MONOTHERAPY; REMISSION; RHEUMATOID ARTHRITIS; SCLERODERMA;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SCLERODERMA, LOCALIZED;

EID: 84880939984     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2013.1929     Document Type: Article

References (5)

1. Krieg T, Hunzelmann N, Gabrielli A, Jablonska S. EDF. Scleroderma. Eur J Dermatol 2008; 18: 213-4.
2. Ramirez J, Hernandez MV, Galve J, Cãnete JD, Sanmarti R. Morphea associated with the use of adalimumab: a case report and review of the literature. Mod Rheumatol 2012; 22: 602-4.
3. Hasegawa M. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis. J Dermatol 2010; 37: 3-10.
4. Daoussis D, Liossis SN, Tsamandas AC, et al. Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study. Rheumatology 2010; 49: 271-80.
5. van Laar JM. B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis. Arthritis Res Ther 2010; 12: 112.